Molecular mechanisms of underlying genetic factors and associated mutations for drug resistance in Mycobacterium tuberculosis
ABSTRACTNowadays, drug-resistant tuberculosis (DR-TB) and co-infected tuberculosis (CI-TB) strains are the leading cause for the enhancement of long-term morbidity and unpredicted mortality rates from this ghoulish acid fast-bacterium infection, globally. Unfortunately, the lack of/ample lethargic t...
Main Authors: | Shasank S. Swain, Divakar Sharma, Tahziba Hussain, Sanghamitra Pati |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2020-01-01
|
Series: | Emerging Microbes and Infections |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/22221751.2020.1785334 |
Similar Items
-
Prevalence and detection of drug resistant mutations in Mycobacterium tuberculosis among drug naïve patients in Nairobi, Kenya
by: Collins Otieno Ogari, et al.
Published: (2019-03-01) -
Editorial: New Approaches Against Drug-Resistant M. tuberculosis
by: Yossef Av-Gay, et al.
Published: (2021-04-01) -
Drug Resistance Conferring Mutation and Genetic Diversity of Mycobacterium tuberculosis Isolates in Tuberculosis Lymphadenitis Patients; Ethiopia
by: Ayalew S, et al.
Published: (2021-02-01) -
Drug resistance-conferring mutations in Mycobacterium tuberculosis from pulmonary tuberculosis patients in Southwest Ethiopia
by: Mulualem Tadesse, et al.
Published: (2016-01-01) -
The Patterns of Acquiring Anti-Mycobacterial Drug Resistance by Susceptible Strains of Mycobacterium tuberculosis
by: Kyutaeg Lee, et al.
Published: (2021-06-01)